Biopharmaceutical Leader Kiniksa Poised To Hit New Buy Point After Big Revenue Beat

Biotech leader Kiniksa stock is poised to hit a fresh buy point after shares soared 25% in response to better-than-expected sales numbers. The post Biopharmaceutical Leader Kiniksa Poised To Hit New Buy Point After Big Revenue Beat appeared first on Investor's Business Daily.

Read it at Investor's Business Daily ↗

← Front page